U.S., April 16 -- An application to own the trademark for 'NUGALVIQ' has been filed on Oct. 07, 2024.
Owner(s):
Applied Therapeutics, Inc.; 545 Fifth Avenue, Suite 1400, , New York
Goods and/or Services:
For: Pharmaceutical preparations for treatment of rare orphan diseases; Pharmaceutical preparations for treatment of diseases that impact sugar and glucose metabolism; Pharmaceutical preparations for inhibiting aldose reductase; Pharmaceutical preparations for treatment of galactosemia, sorbitol dehydrogenase (SORD) deficiency and PMM2-congenital disorder of glycosylation (PMM2-CDG)
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2025-04-15&serialNumbe...